- Movianto UK, specialist for pharmaceutical and healthcare logistics and part of Yusen Logistics Healthcare, has been awarded a five-year contract by NHS England
- End-to-end service includes storage, management and distribution of vaccines to more than 11,000 healthcare locations across England
- Partnership makes use of Movianto UK’s existing logistics network instead of using new dedicated logistics capabilities, supporting NHS England’s sustainable procurement ambitions through more efficient use of logistics infrastructure and reduced transport activity
12 August 2026, Bedford — Movianto UK today announced the go-live of its new national contract with National Health Service (NHS) England for the delivery of specialised pharmaceutical logistics and warehouse services supporting England’s national vaccination and immunisation programmes. The five-year contract is the result of a tender process. It establishes Movianto UK as NHS England’s strategic logistics partner responsible for the end-to-end supply chain solution supporting vaccine storage, inventory management, order fulfilment, sortation and GDP-compliant temperature-controlled distribution to more than 11,000 frontline healthcare locations across England.
“The partnership brings together one of Europe’s most advanced healthcare logistics networks with NHS England’s national vaccination programmes, creating a more resilient, agile and efficient supply chain capable of supporting routine immunisation, national screening programmes and emergency public health responses”, says Andy Robinson, Deputy Managing Director, Movianto UK.
Multi-user logistics model creates synergies
Rather than relying on dedicated warehousing and transport infrastructure solely for NHS England, the solution harnesses Movianto UK’s existing healthcare storage and logistics network, already supporting leading global pharmaceutical manufacturers, NHS organisations and UK Government departments. Again, Andy Robinson: “This shared-user operating model maximises utilisation of existing infrastructure, reduces duplication of resources and delivers improved value through greater operational efficiency.”
It also enables suppliers to move products directly into Movianto’s existing regulated storage network, significantly reducing unnecessary physical stock transfers between facilities before distribution to NHS providers. This streamlined approach improves responsiveness, reduces handling, minimises transport movements and supports wider Government and NHS sustainability ambitions, which seek to reduce carbon emissions across NHS procurement while delivering greater social value.
Experience in supporting national healthcare resilience
The new contract builds upon Movianto UK’s established experience supporting national healthcare resilience, including pandemic preparedness, emergency response capability and time-critical deployment of medicines and vaccines across the United Kingdom.
This year in July, a key demonstration of this capability came during the emergency mobilisation of the national Meningococcal Group B (MenB) vaccination programme for young people. Working at pace alongside NHS England and national stakeholders, Movianto UK rapidly mobilised additional operational capacity to ensure vaccines reached community pharmacies and other vaccination providers on time and in full, supporting the accelerated public health response following the widely reported meningococcal disease cases affecting university students in Kent. As of now, over 16,000 orders have been processed and delivered.
Operating model that benefits patients and the NHS alike
“The successful mobilisation demonstrated the resilience, flexibility and responsiveness of the new national logistics model and highlighted the importance of an established pharmaceutical supply chain capable of responding rapidly to emerging public health priorities”. Andy Robinson adds: “We are proud to partner with NHS England in delivering one of the UK’s most strategically important healthcare supply chains. This contract recognises the value of harnessing existing pharmaceutical infrastructure to create a smarter, more efficient operating model that benefits patients and the NHS alike. Our shared-user approach combines GDP-compliant warehousing, advanced inventory management and nationwide temperature-controlled distribution to provide a resilient platform capable of supporting routine healthcare delivery while remaining ready to respond rapidly during national emergencies.”
Neil Gibbens, Deputy Director of Performance and Delivery Improvement, NHS England, comments:
“The contract represents another significant milestone in NHS England’s commitment to modernising national healthcare logistics through strategic partnerships that combine operational excellence, innovation, sustainability and value for money while strengthening resilience across the UK’s healthcare supply chain. The successful mobilisation of the MenB vaccination programme demonstrated exactly why resilient national logistics capability is so important in responding rapidly to changing public health needs.”
About Movianto
Movianto, since 2025 part of Yusen Logistics, offers a one-stop-shop service for the distribution of healthcare products, and is market leader for logistics and transport in the pharmaceutical and healthcare industry in Europe. Movianto strives to be the preferred logistics partner for this industry and to provide the best service for pharmaceutical and biotech products, medical devices, and diagnostics. As an outsourcing partner along the logistics chain for such products, Movianto offers temperature-controlled warehouse logistics and transport, as well as complete solutions such as order to cash.
Movianto’s international customers benefit from the worldwide Yusen network, a broad range of pharmaceutical logistics services, unique industry expertise, and standardized processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,700 people, has over 600,000 pallet spaces in its network of 23 own logistics centers in eleven European countries and operates throughout Europe. www.movianto.com
About Yusen Logistics
Yusen Logistics partners with businesses around the world to build resilient, efficient, future ready supply chains. With more than 30,000 employees in over 733 locations across 47 countries and regions, our services span international freight forwarding, contract logistics, land transportation, and end to end supply chain management.
Headquartered in Tokyo, we are proud to be a wholly-owned subsidiary of NYK Group, which is Japan’s largest shipping company and listed on the Tokyo Stock Exchange. Driven by a commitment to continuous improvement and sustainability, our ambition is to become the world’s preferred supply chain partner.
We connect. We create. We commit.
Photos (free for editorial use):
Transparent supply chain: Every new step in the supply chain – from warehousing through pick & pack to final delivery is steered and documented by scanning the barcode of a shipment
Contact for press enquiries:
Yusen Logistics Global Management Co., Ltd.
Corporate Branding & Communications Unit
ghqcomms@jp.yusen-logistics.com
Laure Murat (she/her)
Movianto Marketing and Communications
Tel +33 7 60 94 88 01
laure.murat@movianto.com
Ludwig-Michael Cremer (he/him)
External press office – Movianto
Tel +49 7071 640 315
team@log-pr.de
We look forward to receiving digital or physical specimen copies.
If you do not wish to receive any further press releases from Movianto, please send a short e-mail to team@log-pr.de.